Alcon Inc

ALC

Company Profile

  • Business description

    Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

  • Contact

    Chemin de Blandonnet 8
    Royce Bedward
    Vernier
    Geneva1214
    CHE

    T: +41 589112110

    https://www.alcon.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    25,599

Stocks News & Analysis

stocks

A top global stock to buy after a big change in its forecast

Undervalued by 24%, this wide-moat stock is a buy now.
stocks

Does the AI trade still have room to run?

Where Morningstar analysts see opportunities—and where they don’t.
stocks

More gas left in the tank for ASX highflyer

Shares jumped after results and are screening as overvalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,189.9015.700.17%
CAC 408,131.1511.90-0.15%
DAX 4024,933.0832.370.13%
Dow JONES (US)49,412.40313.690.64%
FTSE 10010,148.855.410.05%
HKSE26,765.52135.560.51%
NASDAQ23,601.36100.110.43%
Nikkei 22552,885.25803.64-1.50%
NZX 50 Index13,423.3937.35-0.28%
S&P 5006,950.2334.620.50%
S&P/ASX 2008,860.1015.000.17%
SSE Composite Index4,132.603.56-0.09%

Market Movers